勁馬產(chǎn)品文獻:大鼠抗酒石酸酸性磷酸酶（TRAP）ELISA試劑盒文獻

【資料簡介】

【文獻標題】The participation of fibroblast growth factor 23 (FGF23）in the progression of osteoporosis via JAK/STAT pathway

【作者】Lijun Xu, Lixia Zhang,Huijuan Zhang,et.al

【作者單位】鄭州大學第一附屬醫(yī)院(The First Affiliated Hospital of Zhengzhou University)

【文獻中引用產(chǎn)品】

大鼠抗酒石酸酸性磷酸酶（TRAP）ELISA試劑盒

【關鍵詞】Osteoporosis; FGF23; JAK/STAT pathway; bone metabolism; cartilage metabolism

【DOI】10.1002/jcb.26332

【影響因子(IF)】2.9

【出版期刊】《Journal of Cellular Biochemistry》

【產(chǎn)品原文引用】

Measurement of serum FGF23, osteocalcin, ALP, BALP, TRAP and CTX-I

Serum FGF23 levels were measured by an enzyme linked immunosorbent assay (ELISA) using an FGF23 kit (Kainos Laboratories, Tokyo, Japan). Serum osteocalcin content was determined by ELISA using an Osteocalcin EIA kit (Xinyubio-Technology, China). ALP activity was determined by ELISA using an ALP activity kit (Nanjing Jiancheng Biotech, China). BALP was measured by an electrochemilumi-nescence immunoassay (ECL) using the Access Ostase kit (Beckman Coulter Inc, USA). TRAP activity was determined by ELISA using the Acid-Phosphatase Kit (Shanghai Jinma Biological Technology, China). CTX-I was also measured by ECL using the Elecsys-CrossLaps/serum kit (Roche, USA).

完整版PDF文獻請咨詢在線客服或dian話聯(lián)系我司業(yè)務員！

更多公司福利請關注“上海勁馬”微信公眾號！